In this experiment, the expression of miRNA targeting BSP for 3 weeks led to a significant reduction of the soft tissue tumors and the osteolytic lesions in B3 and B7 cell clones, respectively, compared to the control groups (p<0.03). This evidence concerns the gene IBSP and soft tissue neoplasm.